<ul>
<li>Option Care Health, Inc. 之前因患者留存率下降和治療組合變化下調了 2026 年的指引，這引發了多項證券法調查，並對其近期前景提出了質疑。</li>
<li>與此同時，內部人士的股票購買和高層領導即將舉行的會議評論為投資者評估公司的未來方向增添了額外的背景信息。</li>
<li>由於指引修訂與患者留存率下降和治療組合變化相關，我們將探討這一發展如何重塑 Option Care Health 的投資敍事。</li>
</ul>
<p>人工智能即將改變醫療保健。這 32 只股票正在從早期診斷到藥物發現等各個方面進行探索。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前佈局。</p>
<h2>Option Care Health 投資敍事回顧</h2>
<p>要擁有 Option Care Health，您需要相信其家庭和替代場所輸液模式能夠在治療組合變化和患者留存率下降的壓力下保持韌性。目前，短期內的關鍵催化劑是管理層在 2026 年指引下調後能多快穩定留存率和治療組合，而最大風險是這些趨勢持續存在並繼續壓縮利潤率。最近的律師事務所調查突顯了這種不確定性，但並不會單獨改變運營基本面。</p>
<p>最近最相關的發展是 2026 年指引的修訂，預計淨收入削減至 57.675 億至 57.775 億美元，因留存率和治療組合下降，導致股價下跌 26.4%。在這種背景下，首席執行官和首席財務官在美國銀行全球醫療會議上的即將評論顯得尤為重要，因為這可能會闡明領導層如何計劃重建慢性病量和管理支付方及治療組合風險，這現在是短期表現的核心焦點。</p>
<p>然而，在內部人士購買和指引重置的背後，治療組合變化帶來的持續利潤壓力風險仍然是投資者需要關注的...</p>
<p>閲讀關於 Option Care Health 的完整敍事（免費！）</p>
<p>Option Care Health 的敍事預計到 2029 年收入為 69 億美元，收益為 3.029 億美元。</p>
<p>揭示 Option Care Health 的預測如何得出 30.73 美元的公允價值，相較於當前價格有 57% 的上漲空間。</p>
<h2>探索其他視角</h2>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9aac0566-8088-48b7-9e98-e2064f7c1608/chart/quote-price?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9aac0566-8088-48b7-9e98-e2064f7c1608/chart/quote-price"/></p>
<p>OPCH 1 年股票價格走勢圖</p>
<p>在此消息之前，最悲觀的分析師已經假設年收入增長僅約 5.9%，到 2029 年大約為 67 億美元，並將診所建設成本視為利潤的主要制約因素，這提醒您對 Option Care Health 的看法可能會有很大差異，並可能需要在留存率和組合數據演變時重新考慮。</p>
<p>探索關於 Option Care Health 的另外兩個公允價值估計——為什麼該股票可能比當前價格高出 57%！</p>
<h2>形成您自己的判斷</h2>
<p>不同意現有敍事？非凡的投資回報很少來自隨大流，因此請遵循您的直覺。</p>
<ul>
<li>開始您對 Option Care Health 研究的一個很好的起點是我們的分析，突出了 3 個關鍵收益和 1 個可能影響您投資決策的重要警示信號。</li>
<li>我們的免費 Option Care Health 研究報告提供了全面的基本面分析，匯總在一個視覺圖中——雪花圖，使您能夠一目瞭然地評估 Option Care Health 的整體財務健康狀況。</li>
</ul>
<h2>尋找替代機會？</h2>
<p>我們的每日掃描揭示了具有突破潛力的股票。不要錯過這個機會：</p>
<ul>
<li>揭示下一個大事件，27 只精英便士股票在風險與回報之間取得平衡。</li>
<li>超越巨頭：這 16 只早期階段的人工智能股票可能為您的退休提供資金。</li>
<li>工作的未來已經到來。發現 33 只在人工智能驅動的自動化和工業轉型中引領潮流的頂級機器人和自動化股票。</li>
</ul>
<p><em>本文由 Simply Wall St 撰寫，內容具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，僅使用無偏見的方法，我們的文章並不旨在提供財務建議。</strong> 它不構成購買或出售任何股票的推薦，也未考慮您的目標或財務狀況。我們旨在為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
<h3><strong>新：</strong> AI 股票篩選器和提醒</h3>
<p>我們的新 AI 股票篩選器每天掃描市場以發現機會。</p>
<p>• 分紅強勁的股票（收益率 3% 以上）</p>
<p>• 具有內部人士購買的被低估小盤股</p>
<p>• 高增長的科技和人工智能公司</p>
<p>或從 50 多個指標中構建您自己的篩選器。</p>
<p>立即免費探索</p>

拜爾斯普保健

美國醫療保健供應商 ETF - iShares

醫療業 ETF - Vanguard

標普全球醫療股指數 ETF - iShares

標普醫療保健服務 ETF - SPDR

醫療業 ETF - SPDR

<p>Option Care Health, Inc. 將其 2026 年的收入指引下調至 57.5 億至 57.75 億美元，原因是患者留存率和治療組合較弱，導致股價下跌 26.4%。內部人士的買入和即將發佈的管理層評論可能會為穩定這些問題提供見解。分析師預計該股當前價格有潛在 57% 的上漲空間，但仍存在持續的利潤壓力風險。投資者被鼓勵評估公司的財務健康狀況，並考慮其他投資機會</p>

<ul>
<li>Option Care Health, Inc. previously cut its 2026 guidance due to weaker patient retention and a changed therapy mix, prompting multiple securities law investigations and raising questions about its recent outlook.</li>
<li>At the same time, insider share purchases and upcoming conference commentary from senior leadership add an extra layer of context for investors assessing the company’s future direction.</li>
<li>With the guidance revision tied to weaker patient retention and therapy mix, we’ll examine how this development reshapes Option Care Health’s investment narrative.</li>
</ul>
<div class="lb-trans"><ul>
<li>Option Care Health, Inc. 之前因患者留存率下降和治療組合變化下調了 2026 年的指引，這引發了多項證券法調查，並對其近期前景提出了質疑。</li>
<li>與此同時，內部人士的股票購買和高層領導即將舉行的會議評論為投資者評估公司的未來方向增添了額外的背景信息。</li>
<li>由於指引修訂與患者留存率下降和治療組合變化相關，我們將探討這一發展如何重塑 Option Care Health 的投資敍事。</li>
</ul>
</div><p>AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.</p>
<div class="lb-trans"><p>人工智能即將改變醫療保健。這 32 只股票正在從早期診斷到藥物發現等各個方面進行探索。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前佈局。</p>
</div><h2>Option Care Health Investment Narrative Recap</h2>
<div class="lb-trans"><h2>Option Care Health 投資敍事回顧</h2>
</div><p>To own Option Care Health, you need to believe its home and alternate site infusion model can remain resilient despite pressure from shifting therapy mix and softer patient retention. Right now, the key short term catalyst is how quickly management can stabilize retention and mix after the 2026 guidance cut, while the biggest risk is that these trends linger and keep compressing margins. The recent law firm investigations highlight this uncertainty but do not, by themselves, change the operating fundamentals.</p>
<div class="lb-trans"><p>要擁有 Option Care Health，您需要相信其家庭和替代場所輸液模式能夠在治療組合變化和患者留存率下降的壓力下保持韌性。目前，短期內的關鍵催化劑是管理層在 2026 年指引下調後能多快穩定留存率和治療組合，而最大風險是這些趨勢持續存在並繼續壓縮利潤率。最近的律師事務所調查突顯了這種不確定性，但並不會單獨改變運營基本面。</p>
</div><p>The most relevant recent development is the 2026 guidance revision, which trims expected net revenue to US$5.675–5.775 billion after weaker retention and mix, and triggered a 26.4% share price drop. In that context, upcoming commentary from the CEO and CFO at the Bank of America Global Healthcare Conference matters, as it may clarify how leadership plans to rebuild chronic volumes and manage payer and therapy mix risk, now a central focus for near term performance.</p>
<div class="lb-trans"><p>最近最相關的發展是 2026 年指引的修訂，預計淨收入削減至 57.675 億至 57.775 億美元，因留存率和治療組合下降，導致股價下跌 26.4%。在這種背景下，首席執行官和首席財務官在美國銀行全球醫療會議上的即將評論顯得尤為重要，因為這可能會闡明領導層如何計劃重建慢性病量和管理支付方及治療組合風險，這現在是短期表現的核心焦點。</p>
</div><p>Yet beneath the insider buying and guidance reset, one risk around sustained margin pressure from therapy mix shifts remains something investors should be aware of...</p>
<div class="lb-trans"><p>然而，在內部人士購買和指引重置的背後，治療組合變化帶來的持續利潤壓力風險仍然是投資者需要關注的...</p>
</div><p>Read the full narrative on Option Care Health (it's free!)</p>
<div class="lb-trans"><p>閲讀關於 Option Care Health 的完整敍事（免費！）</p>
</div><p>Option Care Health's narrative projects $6.9 billion revenue and $302.9 million earnings by 2029.</p>
<div class="lb-trans"><p>Option Care Health 的敍事預計到 2029 年收入為 69 億美元，收益為 3.029 億美元。</p>
</div><p>Uncover how Option Care Health's forecasts yield a $30.73 fair value, a 57% upside to its current price.</p>
<div class="lb-trans"><p>揭示 Option Care Health 的預測如何得出 30.73 美元的公允價值，相較於當前價格有 57% 的上漲空間。</p>
</div><h2>Exploring Other Perspectives</h2>
<div class="lb-trans"><h2>探索其他視角</h2>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9aac0566-8088-48b7-9e98-e2064f7c1608/chart/quote-price" alt="" original-src="https://images.simplywall.st/company/9aac0566-8088-48b7-9e98-e2064f7c1608/chart/quote-price"/></p>
<p>OPCH 1-Year Stock Price Chart</p>
<div class="lb-trans"><p>OPCH 1 年股票價格走勢圖</p>
</div><p>Before this news, the most pessimistic analysts already assumed only about 5.9% annual revenue growth to roughly US$6.7 billion by 2029 and saw clinic build out costs as a key brake on margins, reminding you that views on Option Care Health can differ sharply and may need reconsidering as retention and mix data evolve.</p>
<div class="lb-trans"><p>在此消息之前，最悲觀的分析師已經假設年收入增長僅約 5.9%，到 2029 年大約為 67 億美元，並將診所建設成本視為利潤的主要制約因素，這提醒您對 Option Care Health 的看法可能會有很大差異，並可能需要在留存率和組合數據演變時重新考慮。</p>
</div><p>Explore 2 other fair value estimates on Option Care Health - why the stock might be worth as much as 57% more than the current price!</p>
<div class="lb-trans"><p>探索關於 Option Care Health 的另外兩個公允價值估計——為什麼該股票可能比當前價格高出 57%！</p>
</div><h2>Form Your Own Verdict</h2>
<div class="lb-trans"><h2>形成您自己的判斷</h2>
</div><p>Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.</p>
<div class="lb-trans"><p>不同意現有敍事？非凡的投資回報很少來自隨大流，因此請遵循您的直覺。</p>
</div><ul>
<li>A great starting point for your Option Care Health research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.</li>
<li>Our free Option Care Health research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Option Care Health's overall financial health at a glance.</li>
</ul>
<div class="lb-trans"><ul>
<li>開始您對 Option Care Health 研究的一個很好的起點是我們的分析，突出了 3 個關鍵收益和 1 個可能影響您投資決策的重要警示信號。</li>
<li>我們的免費 Option Care Health 研究報告提供了全面的基本面分析，匯總在一個視覺圖中——雪花圖，使您能夠一目瞭然地評估 Option Care Health 的整體財務健康狀況。</li>
</ul>
</div><h2>Looking For Alternative Opportunities?</h2>
<div class="lb-trans"><h2>尋找替代機會？</h2>
</div><p>Our daily scans reveal stocks with breakout potential. Don't miss this chance:</p>
<div class="lb-trans"><p>我們的每日掃描揭示了具有突破潛力的股票。不要錯過這個機會：</p>
</div><ul>
<li>Uncover the next big thing with 27 elite penny stocks that balance risk and reward.</li>
<li>Outshine the giants: these 16 early-stage AI stocks could fund your retirement.</li>
<li>The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.</li>
</ul>
<div class="lb-trans"><ul>
<li>揭示下一個大事件，27 只精英便士股票在風險與回報之間取得平衡。</li>
<li>超越巨頭：這 16 只早期階段的人工智能股票可能為您的退休提供資金。</li>
<li>工作的未來已經到來。發現 33 只在人工智能驅動的自動化和工業轉型中引領潮流的頂級機器人和自動化股票。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>本文由 Simply Wall St 撰寫，內容具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，僅使用無偏見的方法，我們的文章並不旨在提供財務建議。</strong> 它不構成購買或出售任何股票的推薦，也未考慮您的目標或財務狀況。我們旨在為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
</div><h3><strong>New:</strong> AI Stock Screener &amp; Alerts</h3>
<div class="lb-trans"><h3><strong>新：</strong> AI 股票篩選器和提醒</h3>
</div><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p>
<div class="lb-trans"><p>我們的新 AI 股票篩選器每天掃描市場以發現機會。</p>
</div><p>• Dividend Powerhouses (3%+ Yield)</p>
<div class="lb-trans"><p>• 分紅強勁的股票（收益率 3% 以上）</p>
</div><p>• Undervalued Small Caps with Insider Buying</p>
<div class="lb-trans"><p>• 具有內部人士購買的被低估小盤股</p>
</div><p>• High growth Tech and AI Companies</p>
<div class="lb-trans"><p>• 高增長的科技和人工智能公司</p>
</div><p>Or build your own from over 50 metrics.</p>
<div class="lb-trans"><p>或從 50 多個指標中構建您自己的篩選器。</p>
</div><p>Explore Now for Free</p>
<div class="lb-trans"><p>立即免費探索</p>
</div>

What Option Care Health (OPCH)'s Guidance Cut and Insider Buying Signal Means For Shareholders

Simplywall

美國銀行

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

拜爾斯普保健（OPCH）指導下調和內部購買信號對股東的意義是什麼